Fosgonimeton (ATH-1017) is a structurally distinct small-molecule prodrug developed by Athira Pharma as a positive modulator of HGF/c-Met signaling the same mechanism class as Dihexa, but a different molecule
Everyones skin is different, and even the gentlest products can cause side effects
Bubp J, Jen M, Matuszewski K (2015) Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)Deficient Patients: Implications for Pharmacy
doi: 10.1080/08923973.2021.1889583 49
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021